Mitochondrial Dysfunction in the Pathogenesis and Treatment of Oral Inflammatory Diseases

被引:13
|
作者
Dong, Zhili [1 ,2 ]
Wu, Liping [1 ,2 ]
Hong, Hong [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Hosp Stomatol, Guangzhou 510055, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Peoples R China
基金
中国国家自然科学基金;
关键词
mitochondrial dysfunction; oxidative stress; redox balance; periodontitis pathogenesis; periodontitis treatment; OXIDATIVE STRESS; PERIODONTITIS; TRIGGER; OSTEORADIONECROSIS; ATHEROSCLEROSIS; THERAPY; CELLS; RISK; JAW; DNA;
D O I
10.3390/ijms242015483
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral inflammatory diseases (OIDs) include many common diseases such as periodontitis and pulpitis. The causes of OIDs consist microorganism, trauma, occlusal factors, autoimmune dis-eases and radiation therapy. When treated unproperly, such diseases not only affect oral health but also pose threat to people's overall health condition. Therefore, identifying OIDs at an early stage and exploring new therapeutic strategies are important tasks for oral-related research. Mitochondria are crucial organelles for many cellular activities and disruptions of mitochondrial function not only affect cellular metabolism but also indirectly influence people's health and life span. Mitochondrial dysfunction has been implicated in many common polygenic diseases, including cardiovascular and neurodegenerative diseases. Recently, increasing evidence suggests that mitochondrial dysfunction plays a critical role in the development and progression of OIDs and its associated systemic diseases. In this review, we elucidated the critical insights into mitochondrial dysfunction and its involvement in the inflammatory responses in OIDs. We also summarized recent research progresses on the treatment of OIDs targeting mitochondrial dysfunction and discussed the underlying mechanisms.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Oral tolerance in the treatment of inflammatory autoimmune diseases
    Wardrop III R.M.
    Whitacre C.C.
    Inflammation Research, 1999, 48 (3) : 106 - 119
  • [22] Oral tolerance in the treatment of inflammatory autoimmune diseases
    Wardrop, RM
    Whitacre, CC
    INFLAMMATION RESEARCH, 1999, 48 (03) : 106 - 119
  • [23] Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment
    Yang, Jiaqi
    Guo, Qianyun
    Feng, Xunxun
    Liu, Yang
    Zhou, Yujie
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [24] Therapeutic approaches to mitochondrial dysfunction in the treatment of neurodegenerative diseases
    Beal, MF
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 : 58 - 58
  • [25] Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia
    Hu, Xiang-Qun
    Zhang, Lubo
    CURRENT HYPERTENSION REPORTS, 2022, 24 (06) : 157 - 172
  • [26] Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia
    Xiang-Qun Hu
    Lubo Zhang
    Current Hypertension Reports, 2022, 24 : 157 - 172
  • [27] Mitochondrial Dysfunction in Lung Pathogenesis
    Piantadosi, Claude A.
    Suliman, Hagir B.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 79, 2017, 79 : 495 - 515
  • [28] Mitochondrial dysfunction: a key player in the pathogenesis of cardiovascular diseases linked to air pollution
    Boovarahan, Sri Rahavi
    Kurian, Gino A.
    REVIEWS ON ENVIRONMENTAL HEALTH, 2018, 33 (02) : 111 - 122
  • [29] Neuropathology and pathogenesis of mitochondrial diseases
    Brown, GK
    Squier, MV
    JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (04) : 553 - 572
  • [30] Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases
    Kempski, Jan
    Huber, Samuel
    INNERE MEDIZIN, 2022, 63 (10): : 1022 - 1027